Patent · US Expired

Phosphodiesterase and genes thereof

US7332317B2 · kind B2 · utility

3Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2000
Grant dateFeb 19, 2008
Priority date
Expiry dateDec 18, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2521/119
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39 in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.